Cancer survival rates are usually discussed in terms of 5-year relative survival, which refers to the proportion of patients still alive 5 years after diagnosis. Keep in mind that statistics like these are based on large groups of people and cannot predict what might happen with an individual patient.
In the United States, an estimated 65,620 women will be diagnosed with uterine or endometrial cancer this year. About 12,500 women die from uterine cancer each year.
Overall, the five-year survival rate for women with uterine cancer is 85%, however, statistics show marked differences, called cancer health disparities, between white women and black women. Among white women, the five-year survival is 84%, compared to 62% for black women. Black women are less likely to have their disease diagnosed at an early stage, and they are more likely to develop more aggressive and difficult to treat cancer types.
The causes of disparities such as these are complex and are the focus of ongoing research across the country, including here at Roswell Park.
Survival is largely dependent on your cancer’s stage at the time of diagnosis, and national data shows these survival rates for uterine cancer:
|State of disease at diagnosis
|Five-year survival rate
|Localized disease (such as stage 1 and stage 2) where the cancer was confined to the original location
|Regional disease (such as stage 3)
|Distant disease (stage 4) where the cancer has already spread to other body areas